证券记录 · 已归档季度
ZLAB
Zai Lab Limited · Healthcare · Biotechnology
13被追踪持有人
-2Δ持有人
15.41M持有股份
$522.27M报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -13.3% ·
股份流向 -2.4% ·
净新建仓位 -15.4%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 40 | -10 | 13.04M | $247.56M | +1 | −11 |
| Q1 2026 | 51 | -8 | 9.02M | $169.34M | +7 | −15 |
| Q4 2025 | 58 | 0 | 14.32M | $252.66M | +1 | −1 |
| Q3 2025 | 13 | -2 | 15.41M | $522.27M | — | −2 |
| Q2 2025 | 12 | -2 | 15.57M | $544.48M | — | −2 |
| Q1 2025 | 12 | 0 | 13.16M | $475.75M | — | — |
| Q4 2024 | 12 | 0 | 16.81M | $440.22M | +1 | −1 |
| Q3 2024 | 11 | +1 | 20.32M | $490.64M | +1 | — |
| Q2 2024 | 10 | — | 17.23M | $298.54M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 6.08M | +0.7% | $205.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 4.70M | -24.1% | $159.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Wellington Management ✦ | 1.72M | +24.8% | $58.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 987.04K | +169.5% | $33.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 987.04K | +169.5% | $33.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 948.67K | +519.9% | $32.15M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 473.56K | +4.0% | $16.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | BlackRock ✦ (被动) | 473.56K | +4.0% | $16.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | BlackRock ✦ (被动) | 473.56K | +4.0% | $16.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (被动) | 136.34K | -1.7% | $4.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 119.88K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 82.18K | — | $2.79M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 61.40K | +151.1% | $2.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | Marshall Wace ✦ | 61.40K | +151.1% | $2.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | Geode Capital Management ✦ (被动) | 50.58K | -10.5% | $1.71M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | D. E. Shaw & Co. ✦ | 34.29K | -87.7% | $1.16M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 18.81K | — | $637,604 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $8.83M | 曾为 0.0% |
| Renaissance Technologies | $8.14M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 97 持有人, 28.24M 股份, $515.77M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Chen Yajing
Officer · 260 股 · $7,020
Aug 12
Lis William
Director · 8.51K 股 · $212,650
Aug 11
Chen Yajing
Officer · 619 股 · $15,475
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jun 11
SC 13G — TCG Crossover GP II, LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据